Coronary artery calcium score and N-terminal pro-B-type natriuretic peptide as potential gatekeepers for myocardial perfusion imaging

被引:1
|
作者
Haarmark, Christian [1 ,2 ]
Andersen, Kim Francis [3 ]
Madsen, Claus [1 ]
Zerahn, Bo [1 ]
机构
[1] Univ Hosp Copenhagen, Herlev & Gentofte Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark
[2] Univ Hosp Copenhagen, Bispebjerg Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark
[3] Univ Hosp Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark
关键词
Tc-99m-sestamibi; coronary artery calcium; Coronary heart disease; myocardial perfusion imaging; SPECT; AMERICAN-HEART-ASSOCIATION; COMPUTED-TOMOGRAPHY; TASK-FORCE; CARDIOVASCULAR ANGIOGRAPHY; NUCLEAR CARDIOLOGY; DISEASE; PREDICTION; SOCIETY; RISK; GUIDELINES;
D O I
10.1111/cpf.12363
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Myocardial perfusion imaging (MPI) holds an important place as non-invasive risk assessment in patients with intermediate risk of coronary heart disease (CHD). However, as much as 60-70% of MPI scans are normal. This study evaluates the role of coronary artery calcium scoring (CAC score) and NT-proBNP as potential gatekeepers for MPI. Patients with intermediate risk of CHD referred for standard MPI were included. CAC score and NT-proBNP were both assessed at the day of the stress study. Sensitivity, specificity and NPV for prediction of abnormal MPI scans were calculated for CAC, NT-proBNP and the combination hereof. A total of 190 patients were included (mean age 61 +/- 12 years, 55% female) of whom 24% had known CHD. In all 30% of the scans were abnormal. CAC score achieved the highest AUC regardless of whether patients with known CHD were included or not [AUC 0.75 95% CI (0.66-0.84) and AUC 0.79 (0.68-0.91)]. As a singular variable, CAC score was the most potent predictor with a sensitivity of 85%, specificity of 39% and NPV 88%. The combination of CAC score<10 and NT-proBNP>26 reached a sensitivity of 98% and NPV 94%, where 8% of scans tentatively could be avoided. In patients referred for MPI with intermediate risk for CHD, a combination of CAC score and NT-proBNP could be used to identify a group of patients where MPI could be averted with a high degree of diagnostic safety.
引用
收藏
页码:710 / 716
页数:7
相关论文
共 50 条
  • [1] Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia
    Staub, Daniel
    Jonas, Nils
    Zellweger, Michael J.
    Nusbaumer, Charly
    Wild, Damian
    Pfisterer, Matthias E.
    Mueller-Brand, Jan
    Perruchoud, Andre P.
    Mueller, Christian
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (11): : 1287.e9 - 1287.e16
  • [2] N-terminal pro-B-type natriuretic peptide and mortality in coronary heart disease
    Pöge, U
    Gerhardt, TM
    Woitas, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19): : 2025 - 2025
  • [3] N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization
    Sir, Jung-Ju
    Chung, Woo-Young
    Hwang, Seok-Jae
    Kang, Hyun-Jae
    Cho, Young-Seok
    Koo, Bon-Kwon
    Chae, In-Ho
    Choi, Dong-Ju
    Kim, Hyo-Soo
    Sohn, Dae-Won
    Kim, Cheol-Ho
    Oh, Byung-Hee
    Park, Young-Bae
    Choi, Yun-Shik
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 126 (03) : 322 - 332
  • [4] N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
    Ezekowitz, Justin A.
    O'Connor, Christopher M.
    Troughton, Richard W.
    Alemayehu, Wendimagegn G.
    Westerhout, Cynthia M.
    Voors, Adriaan A.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Emdin, Michele
    Patel, Mahesh J.
    Pieske, Burkert
    Roessig, Lothar
    Hernandez, Adrian F.
    Armstrong, Paul W.
    JACC-HEART FAILURE, 2020, 8 (11) : 931 - 939
  • [5] Utility of Preoperative N-Terminal Pro-B-Type Natriuretic Peptide in the Prognosis of Coronary Artery Bypass Grafting
    Wang, Juncheng
    Liu, Hanning
    Zeng, Juntong
    Su, Xiaoting
    Zhao, Yan
    Zheng, Zhe
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 201 : 131 - 138
  • [6] N-Terminal Pro-B-Type Natriuretic Peptide and Incident CKD
    Sasaki, Takaya
    Oishi, Emi
    Nagata, Takuya
    Sakata, Satoko
    Chen, Sanmei
    Furuta, Yoshihiko
    Honda, Takanori
    Yoshida, Daigo
    Hata, Jun
    Tsuboi, Nobuo
    Kitazono, Takanari
    Yokoo, Takashi
    Ninomiya, Toshiharu
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 976 - 985
  • [7] N-terminal pro-B-type natriuretic peptide and mortality in coronary heart disease - Reply
    Kragelund, C
    Kober, L
    Hildebrandt, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19): : 2026 - 2026
  • [8] N-terminal pro-B-type natriuretic peptide changes in patients with acute coronary syndromes
    Shreyder, K.
    Shakhnovich, R.
    Bosikh, E.
    Ruda, M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 264 - 264
  • [9] Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes
    Coppola, Giuseppe
    Corrado, Egle
    Mule, Maria Cristina
    Augugliaro, Stefano
    Cucchiara, Angela
    Novo, Giuseppina
    Amoroso, Gisella
    Assennato, Pasquale
    Hoffmann, Enrico
    Vitale, Francesco
    Novo, Salvatore
    CORONARY ARTERY DISEASE, 2009, 20 (03) : 225 - 229
  • [10] N-terminal pro-B-type natriuretic peptide as a prognostic marker in acute coronary syndrome
    Kwon, SU
    Baek, KK
    Lim, SH
    Park, JII
    Lim, SJ
    Cho, DK
    Kim, SW
    Choi, JH
    Gwon, HC
    Lee, SH
    Hong, KP
    Park, JE
    Jeon, ES
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 383A - 383A